BOS Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Buy
1,864
+33
+2% +$7.69K 0.11% 127
2026
Q1
$448K Buy
1,831
+99
+6% +$23.1K 0.11% 134
2025
Q4
$358K Sell
1,732
-30
-2% -$5.93K 0.1% 141
2025
Q3
$327K Sell
1,762
-5
-0.3% -$857 0.09% 142
2025
Q2
$270K Sell
1,767
-83
-4% -$12.8K 0.09% 145
2025
Q1
$307K Sell
1,850
-80
-4% -$12.5K 0.11% 123
2024
Q4
$279K Sell
1,930
-40
-2% -$6.2K 0.1% 126
2024
Q3
$319K Sell
1,970
-15
-0.8% -$2.39K 0.12% 113
2024
Q2
$290K Hold
1,985
0.13% 116
2024
Q1
$314K Hold
1,985
0.16% 101
2023
Q4
$311K Sell
1,985
-778
-28% -$119K 0.21% 106
2023
Q3
$430K Buy
2,763
+23
+0.8% +$3.79K 0.32% 73
2023
Q2
$454K Buy
2,740
+136
+5% +$21.9K 0.35% 66
2023
Q1
$404K Buy
2,604
+56
+2% +$9.04K 0.34% 70
2022
Q4
$450K Buy
+2,548
New +$440K 0.4% 66

Other funds holding JNJ

BOS Asset Management's JNJ Position: Q2 2026 in Review

BOS Asset Management increased its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, buying an estimated $7.69K and bringing the position to 1,864 shares worth $473K. The position accounts for 0.11% of the portfolio, ranked #127.

BOS Asset Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BOS Asset Management held 1,864 shares of Johnson & Johnson worth $473K as of Q2 2026.
  • BOS Asset Management bought 33 Johnson & Johnson shares in Q2 2026, an estimated $7.69K.
  • Johnson & Johnson made up 0.11% of BOS Asset Management's portfolio in Q2 2026, its #127 holding.
  • BOS Asset Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.